Donald L. Hagan LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$778K Hold
1,020
0.38% 60
2025
Q2
$795K Hold
1,020
0.4% 60
2025
Q1
$842K Hold
1,020
0.44% 61
2024
Q4
$787K Hold
1,020
0.41% 63
2024
Q3
$904K Hold
1,020
0.46% 54
2024
Q2
$923K Hold
1,020
0.49% 54
2024
Q1
$794K Hold
1,020
0.41% 62
2023
Q4
$595K Hold
1,020
0.32% 62
2023
Q3
$548K Hold
1,020
0.33% 64
2023
Q2
$478K Hold
1,020
0.27% 69
2023
Q1
$350K Hold
1,020
0.19% 77
2022
Q4
$373K Hold
1,020
0.23% 71
2022
Q3
$330K Hold
1,020
0.23% 76
2022
Q2
$331K Hold
1,020
0.21% 80
2022
Q1
$292K Hold
1,020
0.16% 87
2021
Q4
$282K Buy
1,020
+20
+2% +$5.07K 0.15% 94
2021
Q3
$231K Hold
1,000
0.13% 94
2021
Q2
$230K Buy
+1,000
New +$201K 0.14% 90
2016
Q2
Sell
-1,120
Closed -$81K 204
2016
Q1
$81K Buy
+1,120
New +$84.7K 0.07% 110
2015
Q4
Sell
-1,120
Closed -$94K 200
2015
Q3
$94K Buy
+1,120
New +$94.6K 0.08% 98

Other funds holding LLY

Donald L. Hagan LLC's LLY Position: Q3 2025 in Review

Donald L. Hagan LLC held its Eli Lilly (LLY) position steady in Q3 2025 at 1,020 shares worth $778K. The position accounts for 0.38% of the portfolio, ranked #60.

Donald L. Hagan LLC first reported a position in LLY in Q3 2015 and has held it in 20 quarters since. The position peaked at $923K in Q2 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Donald L. Hagan LLC held 1,020 shares of Eli Lilly worth $778K as of Q3 2025.
  • Donald L. Hagan LLC left its Eli Lilly share count unchanged in Q3 2025.
  • Eli Lilly made up 0.38% of Donald L. Hagan LLC's portfolio in Q3 2025, its #60 holding.
  • Donald L. Hagan LLC first reported a position in Eli Lilly in Q3 2015 and has held it in 20 quarters since.
  • Donald L. Hagan LLC's Eli Lilly position peaked at $923K in Q2 2024.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Donald L. Hagan LLC's 13F filing for Q3 2025, filed 16 Oct 2025.